Xiangyu Medical(SH:688626) Xin Lang Cai Jing·2025-08-27 02:13Summary of Key Points Core Viewpoint - The performance of Xiangyu Medical has shown fluctuations in stock price and trading volume, with significant changes in financing activities and revenue generation [1][2]. Group 1: Stock Performance and Financing - On August 26, Xiangyu Medical's stock price dropped by 3.53%, with a trading volume of 183 million yuan [1]. - The financing buy-in amount for Xiangyu Medical on the same day was 27.81 million yuan, while the financing repayment was 36.13 million yuan, resulting in a net financing outflow of 8.32 million yuan [1]. - As of August 26, the total financing and securities lending balance for Xiangyu Medical was 166 million yuan, which accounts for 1.74% of its market capitalization [1]. Group 2: Business Performance - For the period from January to March 2025, Xiangyu Medical reported a revenue of 186 million yuan, reflecting a year-on-year growth of 10.02% [2]. - The net profit attributable to the parent company for the same period was 22.95 million yuan, showing a significant year-on-year decrease of 41.26% [2]. Group 3: Shareholder Information and Dividends - As of March 31, the number of shareholders for Xiangyu Medical was 5,895, which is an increase of 10.48% compared to the previous period [2]. - The company has distributed a total of 277 million yuan in dividends since its A-share listing, with 157 million yuan distributed over the past three years [3]. Group 4: Company Overview - Xiangyu Medical, established on March 20, 2002, is located in Anyang, Henan Province, and specializes in the research, production, and sales of rehabilitation medical devices [1]. - The company's main revenue sources include rehabilitation therapy equipment (67.79%), rehabilitation training equipment (22.13%), and other related products [1].